Invention Grant
US09458137B2 Substituted indol-5-ol derivatives and their therapeutical applications
有权
取代的吲哚-5-醇衍生物及其治疗应用
- Patent Title: Substituted indol-5-ol derivatives and their therapeutical applications
- Patent Title (中): 取代的吲哚-5-醇衍生物及其治疗应用
-
Application No.: US14440817Application Date: 2013-11-05
-
Publication No.: US09458137B2Publication Date: 2016-10-04
- Inventor: Chunlin Tao , Qinwei Wang , David Ho , Tulay Polat , Laxman Nallan , Patrick Soon-Shiong
- Applicant: NantBioScience, Inc.
- Applicant Address: US CA Culver City
- Assignee: NantBioScience, Inc.
- Current Assignee: NantBioScience, Inc.
- Current Assignee Address: US CA Culver City
- Agency: Leydig, Voit & Mayer, Ltd.
- International Application: PCT/US2013/068515 WO 20131105
- International Announcement: WO2014/071378 WO 20140508
- Main IPC: A61K31/506
- IPC: A61K31/506 ; C07D403/14 ; A61K45/06 ; C07D403/12 ; C07D401/14 ; A61K31/5377 ; A61K31/541

Abstract:
The present invention relates generally to the use of compounds to treat a variety of disorders, diseases and pathologic conditions and more specifically to the use of substituted indol-5-ol derivatives to modulate protein kinases and for treating protein kinase-mediated diseases.
Public/Granted literature
- US20150291564A1 SUBSTITUTED INDOL-5-OL DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS Public/Granted day:2015-10-15
Information query
IPC分类: